Birgit Alsbjerg

No ORCID on file · 6 papers in corpus · active 2008-2024

Study types

  • article 4
  • letter 1
  • other 1

Condition tags

  • endometriosis 6
  • adenomyosis 2
article 2024
·doi:10.1093/humrep/deae108.664

Abstract Study question Does subcutaneous (SC) progesterone treatment provide progesterone levels comparable to intramuscular (IM) progesterone when using a cut-off level of 118nmol/l(37.1ng/ml) during intensive luteal phase support? Summar…

other 2024
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.103737

Endometriosis and adenomyosis are distinct clinical conditions that carry the same pathophysiological features. In recent years the clinical focus on assisted reproductive technology patients with either condition (E/A) has increased, in th…

letter 2024
Human Reproduction ·doi:10.1093/humrep/deae202
article 2022
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2022.09.005

RESEARCH QUESTION: What is the optimal serum progesterone cut-off level in patients with endometriosis undergoing hormone replacement therapy frozen embryo transfer (HRT-FET) with intensive progesterone luteal phase support? DESIGN: A coho…

article 2022
·doi:10.1093/humrep/deac107.285

Abstract Study question What is the optimal serum progesterone (P4) cut-off level for endometriosis patients undergoing hormone replacement therapy frozen embryo transfer (HRT-FET) with intensive exogenous progesterone luteal phase support?…

article 2008
Ugeskrift for laeger

We report a case in which a patient received IVF treatment due to massive pelvic endometriosis. The tubal patency and sperm parameters were normal. After e-SET (elective single embryo transfer) ultrasonography showed a triplet pregnancy wit…